Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Prognostic Value of Copeptin for Myocardial Infarct Size and 6-month Prognosis in Patients With ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: GOOD I Study

NCT03074214 is registered in ClinicalTrials.gov with Shengjing Hospital as lead sponsor.

NCT NCT03074214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03074214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Prognostic Value of Copeptin for Myocardial Infarct Size and 6-month Prognosis in Patients With ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: GOOD I Study
Lead sponsor
Shengjing Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 6, 2017
Completion date
August 31, 2019
Enrollment
275 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

st-elevation myocardial infarction